Colonic Oxidative and Mitochondrial Function in Parkinson’s Disease and Idiopathic REM Sleep Behavior Disorder

Table 1

Demographic and clinical data of the subjects included in the study.

	PD	iRBD	Control
Number of patients (M/F)	9 (7/2)	7 (6/1)	9 (4/5)
Age at biopsy (years, median, min-max)	65.18 (54.04–71.02)	72.44 (66.85–83.40)	64.79, (58.34–82.74)
Disease duration (years, median, min-max)	5.77 (0.76–13.81)	10.54 (1.64–22.25)	—
Hoehn and Yahr (median, min-max)	2 (1-2)	—	—
UPDRS I (median, min-max)	10 (1–19)	5 (1–17)	4 (0–9)
UPDRS II (median, min-max)	8 (2–14)	1 (0–8)	0 (0–3)
UPDRS III (median, min-max)	14 (5–34)	4 (1–27)	0 (0–4)
NMSQuest, gastrointestinal subdomain (median, min-max)	6 (0–16)	0 (0–9)	0.5 (0–12)